insulin glargine
insulin glargine is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand names including Insulin glargine U-300, Lantus, TOUJEO Max. Available dosage form: injection, solution.
Drug Details
- Generic Name
- insulin glargine
- Brand Names
- Insulin glargine U-300, Lantus, TOUJEO Max, Insulin glargine U-300 Max, Lantus Solostar, LANTUS SOLOSTAR, TOUJEO, Insulin Glargine Solostar
- Application Number
- BLA206538
- Sponsor
- Sanofi-Aventis U.S. LLC
- NDC Codes
- 12
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- INSULIN GLARGINE
Indications and Usage
1 INDICATIONS AND USAGE LANTUS is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. LANTUS is a long-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 ) Limitations of Use Not recommended for the treatment of diabetic ketoacidosis. ( 1 ) Limitations of Use LANTUS is not recommended for the treatment of diabetic ketoacidosis.